首页> 外文期刊>Cancer Medicine >Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study
【24h】

Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study

机译:鼻咽癌初步诊断后腮腺区淋巴结转移的预后效果:倾向评分匹配研究

获取原文
获取外文期刊封面目录资料

摘要

Abstract Parotid area lymph node (PLN) metastasis in nasopharyngeal carcinoma (NPC) is rare, and its prognosis remains largely unknown. Our study aimed to investigate the prognostic value and staging categories of PLN metastasis in patients with NPC and treated with intensity-modulated radiation therapy (IMRT), to provide a reference for clinical treatment for NPC with PLN metastasis. Records for 1616 untreated NPC patients without distant metastasis was retrospectively reviewed. All patients underwent magnetic resonance imaging (MRI) examination prior to treatment and then received IMRT as their primary treatment. Forty-five NPC patients (2.8%) showed initial PLN metastasis on follow-up MRI. PLN metastasis was significantly associated with the N classification and clinical stage. Univariate analysis showed that PLN metastasis had an unfavorable influence on overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS), and regional relapse-free survival (RRFS) in NPC patients. Using propensity score matching (PSM) to calibrate selection bias and confounding bias, it was observed that PLN metastasis remained an adverse prognostic factor for OS, PFS, DMFS, and RRFS. Furthermore, the 5-year DMFS and RRFS curves for PLN metastasis were significantly separated from that for N2 disease but crossed that for N3 disease. Therefore, PLN metastasis was found to be an adverse prognostic factor for NPC and to be associated with the same DMFS as N3 disease. Therefore, more aggressive therapeutic strategies consistent with those for N3 disease are recommended for NPC with PLN metastasis to reduce distant metastasis.
机译:摘要鼻咽癌(NPC)的腮腺区域淋巴结(PLN)转移很少见,其预后仍不明。本研究旨在探讨PLN转移在NPC患者中的应用及强度调制放射治疗(IMRT)的预后价值和分期类型,为NPC合并PLN转移的临床治疗提供参考。回顾性分析了1616例未经治疗的NPC无远处转移的患者的记录。所有患者在治疗前都要接受磁共振成像(MRI)检查,然后接受IMRT作为主要治疗方法。 45名NPC患者(2.8%)在随访MRI上显示出PLN初始转移。 PLN转移与N分类和临床分期显着相关。单因素分析表明,PLN转移对NPC患者的总生存期(OS),无进展生存期(PFS),远处无转移生存期(DMFS)和区域无复发生存期(RRFS)产生不利影响。使用倾向评分匹配(PSM)校正选择偏倚和混淆偏倚,观察到PLN转移仍然是OS,PFS,DMFS和RRFS的不良预后因素。此外,PLN转移的5年DMFS和RRFS曲线与N2疾病的5年DMFS和RRFS曲线显着分离,但与N3疾病的5年DMFS和RRFS曲线却截然不同。因此,发现PLN转移是NPC的不良预后因素,并且与N3疾病具有相同的DMFS。因此,对于具有PLN转移的NPC,建议采用与N3疾病相一致的更积极的治疗策略,以减少远处转移。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号